Dr Martens Valuation

DOCMF Stock  USD 0.72  0.02  2.86%   
Dr Martens is overvalued. Dr Martens plc owns a latest Real Value of $0.64 per share. The recent price of the firm is $0.72. Our model computes the value of Dr Martens plc from reviewing the firm fundamentals such as Shares Owned By Insiders of 3.85 %, return on asset of 0.16, and Current Valuation of 2.75 B as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
0.72
Please note that Dr Martens' price fluctuation is extremely dangerous at this time. Calculation of the real value of Dr Martens plc is based on 3 months time horizon. Increasing Dr Martens' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the DOCMF pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Dr Martens plc. Since Dr Martens is currently traded on the exchange, buyers and sellers on that exchange determine the market value of DOCMF Pink Sheet. However, Dr Martens' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.72 Real  0.64 Hype  0.72 Naive  0.75
The real value of DOCMF Pink Sheet, also known as its intrinsic value, is the underlying worth of Dr Martens plc Company, which is reflected in its stock price. It is based on Dr Martens' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Dr Martens' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
0.64
Real Value
3.73
Upside
Estimating the potential upside or downside of Dr Martens plc helps investors to forecast how DOCMF pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Dr Martens more accurately as focusing exclusively on Dr Martens' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.690.730.76
Details
Hype
Prediction
LowEstimatedHigh
0.040.723.81
Details
Potential
Annual Dividend
LowForecastedHigh
0.010.010.01
Details

Dr Martens Total Value Analysis

Dr Martens plc is currently expected to have takeover price of 2.75 B with market capitalization of 1.93 B, debt of 280.9 M, and cash on hands of 228 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Dr Martens fundamentals before making investing decisions based on enterprise value of the company
  Takeover PriceMarket CapDebt ObligationsCash
2.75 B
1.93 B
280.9 M
228 M

Dr Martens Investor Information

About 69.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.01. Dr Martens plc last dividend was issued on the 5th of January 2023. Based on the key indicators related to Dr Martens' liquidity, profitability, solvency, and operating efficiency, Dr Martens plc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.

Dr Martens Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Dr Martens has an asset utilization ratio of 105.73 percent. This implies that the Company is making $1.06 for each dollar of assets. An increasing asset utilization means that Dr Martens plc is more efficient with each dollar of assets it utilizes for everyday operations.

Dr Martens Ownership Allocation

Dr Martens plc secures a total of 1 Billion outstanding shares. Over half of Dr Martens' outstanding shares are owned by institutions. These institutions are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company retains, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Dr Martens Profitability Analysis

The company reported the revenue of 908.3 M. Net Income was 181.2 M with profit before overhead, payroll, taxes, and interest of 578.8 M.

Dr Martens Past Distributions to stockholders

Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Dr Martens' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Dr Martens and how it compares across the competition.

About Dr Martens Valuation

The pink sheet valuation mechanism determines Dr Martens' current worth on a weekly basis. Our valuation model uses a comparative analysis of Dr Martens. We calculate exposure to Dr Martens's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Dr Martens's related companies.
Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Martens plc was founded in 1945 and is based in London, the United Kingdom. DR MARTENS operates under Footwear Accessories classification in the United States and is traded on OTC Exchange. It employs 2229 people.

8 Steps to conduct Dr Martens' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Dr Martens' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Dr Martens' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Dr Martens' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Dr Martens' revenue streams: Identify Dr Martens' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Dr Martens' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Dr Martens' growth potential: Evaluate Dr Martens' management, business model, and growth potential.
  • Determine Dr Martens' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Dr Martens' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.
Dr Martens' stock price is the clearest measure of market expectations about its performance. Without stock valuation, investors cannot independently discern whether Dr Martens' value is low or high relative to the company's performance and growth projections. Determining the market value of Dr Martens can be done in different ways, such as multiplying its stock price by its outstanding shares.
A single share of Dr Martens represents a small ownership stake in the entity. As a stockholder of DOCMF, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.

Dr Martens Dividends Analysis For Valuation

Please note that Dr Martens has scaled down on payment of dividends at this time.
There are various types of dividends Dr Martens can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of DOCMF shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Dr Martens plc directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When DOCMF pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Dr Martens by the value of the dividends paid out.

Dr Martens Growth Indicators

Investing in growth stocks can be very risky. If the company such as Dr Martens does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
Common Stock Shares OutstandingB
Quarterly Earnings Growth Y O Y-0.069
Forward Price Earnings0.2392
Retained Earnings1.7 B

Complementary Tools for DOCMF Pink Sheet analysis

When running Dr Martens' price analysis, check to measure Dr Martens' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Martens is operating at the current time. Most of Dr Martens' value examination focuses on studying past and present price action to predict the probability of Dr Martens' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Martens' price. Additionally, you may evaluate how the addition of Dr Martens to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format